CD8A and hepatocellular carcinoma: TACE has also been shown to affect the immunogenic cell death biomarkers in patients with HCC and also affect the immune microenvironment with changes to the CD4+/CD8+ T-cell ratio, increased Th17 cells, decreased Tregs, and increased pro-inflammatory cytokines [250,258,259,260,261].